 Christopher Lowry
Concepts (713)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serotonin | 63 | 2025 | 323 | 10.380 |
Why?
| | Raphe Nuclei | 41 | 2019 | 110 | 9.260 |
Why?
| | Tryptophan Hydroxylase | 34 | 2022 | 53 | 6.120 |
Why?
| | Mycobacterium | 13 | 2024 | 108 | 5.360 |
Why?
| | Serotonergic Neurons | 17 | 2025 | 29 | 4.750 |
Why?
| | Anxiety | 46 | 2024 | 1035 | 4.540 |
Why?
| | Stress, Psychological | 36 | 2025 | 1100 | 4.440 |
Why?
| | Mycobacteriaceae | 13 | 2023 | 24 | 4.400 |
Why?
| | Dorsal Raphe Nucleus | 15 | 2025 | 31 | 3.690 |
Why?
| | Proto-Oncogene Proteins c-fos | 24 | 2025 | 185 | 3.420 |
Why?
| | Amygdala | 21 | 2022 | 191 | 3.330 |
Why?
| | Corticotropin-Releasing Hormone | 18 | 2018 | 68 | 3.310 |
Why?
| | Neurons | 44 | 2022 | 1590 | 3.280 |
Why?
| | Gastrointestinal Microbiome | 21 | 2025 | 697 | 3.220 |
Why?
| | Rats | 84 | 2025 | 5647 | 3.190 |
Why?
| | Fear | 16 | 2023 | 338 | 3.180 |
Why?
| | Behavior, Animal | 27 | 2025 | 501 | 3.150 |
Why?
| | Corticosterone | 25 | 2025 | 236 | 3.110 |
Why?
| | Microbiota | 17 | 2025 | 762 | 2.920 |
Why?
| | Animals | 178 | 2025 | 36940 | 2.500 |
Why?
| | Stress Disorders, Post-Traumatic | 15 | 2025 | 847 | 2.330 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 9 | 2019 | 29 | 2.180 |
Why?
| | Hyperthermia, Induced | 8 | 2024 | 116 | 2.170 |
Why?
| | Depressive Disorder, Major | 11 | 2024 | 364 | 2.090 |
Why?
| | Rats, Wistar | 34 | 2020 | 455 | 2.050 |
Why?
| | Inflammation | 28 | 2025 | 2837 | 2.050 |
Why?
| | Probiotics | 4 | 2025 | 54 | 2.030 |
Why?
| | Anti-Inflammatory Agents | 9 | 2023 | 496 | 1.970 |
Why?
| | Pituitary-Adrenal System | 12 | 2019 | 162 | 1.920 |
Why?
| | Rats, Sprague-Dawley | 35 | 2025 | 2486 | 1.920 |
Why?
| | Antidepressive Agents | 10 | 2024 | 236 | 1.910 |
Why?
| | Hypothalamo-Hypophyseal System | 13 | 2019 | 197 | 1.890 |
Why?
| | Extinction, Psychological | 4 | 2023 | 86 | 1.860 |
Why?
| | Central Nervous System | 10 | 2022 | 258 | 1.730 |
Why?
| | Organic Cation Transport Proteins | 10 | 2025 | 26 | 1.660 |
Why?
| | Mental Health | 8 | 2024 | 726 | 1.650 |
Why?
| | Brain | 29 | 2024 | 2668 | 1.630 |
Why?
| | Anxiety Disorders | 11 | 2021 | 377 | 1.620 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 11 | 2022 | 75 | 1.570 |
Why?
| | Hippocampus | 9 | 2025 | 895 | 1.500 |
Why?
| | Panic Disorder | 7 | 2017 | 24 | 1.490 |
Why?
| | Fluoxetine | 7 | 2025 | 54 | 1.410 |
Why?
| | Male | 139 | 2025 | 67762 | 1.370 |
Why?
| | Hypothalamus | 7 | 2025 | 153 | 1.350 |
Why?
| | Motor Activity | 12 | 2021 | 718 | 1.300 |
Why?
| | Microglia | 6 | 2023 | 251 | 1.250 |
Why?
| | Bacterial Vaccines | 4 | 2018 | 63 | 1.240 |
Why?
| | Glucocorticoids | 6 | 2023 | 594 | 1.230 |
Why?
| | Depression | 14 | 2025 | 1397 | 1.230 |
Why?
| | RNA, Ribosomal, 16S | 14 | 2025 | 549 | 1.220 |
Why?
| | Lipopolysaccharides | 6 | 2023 | 886 | 1.160 |
Why?
| | Citalopram | 2 | 2018 | 29 | 1.140 |
Why?
| | Analysis of Variance | 23 | 2018 | 1316 | 1.130 |
Why?
| | Social Isolation | 3 | 2013 | 62 | 1.110 |
Why?
| | Urocortins | 10 | 2019 | 23 | 1.100 |
Why?
| | Neural Pathways | 13 | 2025 | 295 | 1.100 |
Why?
| | Carbolines | 9 | 2015 | 32 | 1.090 |
Why?
| | Feces | 8 | 2025 | 484 | 1.090 |
Why?
| | Depressive Disorder | 3 | 2018 | 379 | 1.080 |
Why?
| | Vaccines, Inactivated | 3 | 2018 | 68 | 1.070 |
Why?
| | Environment, Controlled | 3 | 2016 | 22 | 1.070 |
Why?
| | Body Temperature Regulation | 7 | 2019 | 97 | 1.040 |
Why?
| | Salamandridae | 11 | 2009 | 33 | 1.030 |
Why?
| | Tryptophan | 9 | 2022 | 183 | 1.010 |
Why?
| | Mood Disorders | 3 | 2013 | 133 | 1.000 |
Why?
| | Immunomodulation | 3 | 2016 | 98 | 0.990 |
Why?
| | Dysbiosis | 2 | 2018 | 181 | 0.980 |
Why?
| | Social Behavior | 8 | 2025 | 287 | 0.960 |
Why?
| | Immunohistochemistry | 20 | 2019 | 1738 | 0.950 |
Why?
| | Cell Count | 14 | 2015 | 324 | 0.950 |
Why?
| | Disease Models, Animal | 20 | 2023 | 4295 | 0.950 |
Why?
| | Anti-Anxiety Agents | 5 | 2023 | 46 | 0.950 |
Why?
| | Serotonin Receptor Agonists | 5 | 2017 | 26 | 0.950 |
Why?
| | Panic | 4 | 2017 | 10 | 0.900 |
Why?
| | RNA, Messenger | 9 | 2020 | 2833 | 0.870 |
Why?
| | Diet, Western | 1 | 2024 | 81 | 0.870 |
Why?
| | Veterans | 8 | 2025 | 1476 | 0.860 |
Why?
| | Stress, Physiological | 11 | 2014 | 443 | 0.860 |
Why?
| | Toxoplasmosis | 5 | 2025 | 40 | 0.850 |
Why?
| | Dorsomedial Hypothalamic Nucleus | 3 | 2015 | 5 | 0.850 |
Why?
| | Arousal | 6 | 2023 | 155 | 0.830 |
Why?
| | Receptor, Serotonin, 5-HT1A | 8 | 2019 | 38 | 0.810 |
Why?
| | Weight Gain | 3 | 2024 | 519 | 0.800 |
Why?
| | Maternal Deprivation | 4 | 2019 | 16 | 0.800 |
Why?
| | Septal Nuclei | 3 | 2019 | 23 | 0.800 |
Why?
| | Caffeine | 5 | 2018 | 68 | 0.780 |
Why?
| | Inflammation Mediators | 3 | 2018 | 513 | 0.780 |
Why?
| | Brain Injuries, Traumatic | 4 | 2020 | 360 | 0.770 |
Why?
| | Reflex, Startle | 4 | 2019 | 65 | 0.770 |
Why?
| | Mental Disorders | 9 | 2024 | 1077 | 0.770 |
Why?
| | Neurons, Afferent | 4 | 2012 | 97 | 0.750 |
Why?
| | Cytomegalovirus Infections | 1 | 2023 | 192 | 0.750 |
Why?
| | Prefrontal Cortex | 3 | 2018 | 301 | 0.740 |
Why?
| | Immunization | 9 | 2022 | 411 | 0.740 |
Why?
| | Toxoplasma | 4 | 2025 | 42 | 0.730 |
Why?
| | Carbon Dioxide | 4 | 2010 | 267 | 0.720 |
Why?
| | Hydroxyindoleacetic Acid | 11 | 2018 | 26 | 0.720 |
Why?
| | Veterans Health | 2 | 2024 | 186 | 0.710 |
Why?
| | Hot Temperature | 3 | 2022 | 391 | 0.700 |
Why?
| | Mice | 33 | 2024 | 17787 | 0.670 |
Why?
| | Colitis | 4 | 2019 | 266 | 0.670 |
Why?
| | Proteome | 1 | 2025 | 472 | 0.660 |
Why?
| | Humans | 98 | 2025 | 137585 | 0.660 |
Why?
| | Body Temperature | 5 | 2024 | 222 | 0.660 |
Why?
| | Exploratory Behavior | 5 | 2021 | 92 | 0.660 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2020 | 8 | 0.660 |
Why?
| | Mice, Inbred BALB C | 12 | 2023 | 1272 | 0.650 |
Why?
| | Environment Design | 2 | 2016 | 27 | 0.630 |
Why?
| | Emotions | 5 | 2023 | 548 | 0.610 |
Why?
| | Interleukin-4 | 1 | 2020 | 216 | 0.610 |
Why?
| | Serotonin Agents | 4 | 2015 | 9 | 0.610 |
Why?
| | Locomotion | 6 | 2021 | 106 | 0.600 |
Why?
| | Synaptic Transmission | 4 | 2018 | 289 | 0.600 |
Why?
| | Dominance-Subordination | 2 | 2011 | 16 | 0.590 |
Why?
| | Porphyromonas gingivalis | 3 | 2025 | 23 | 0.590 |
Why?
| | Genes, fos | 2 | 2010 | 36 | 0.570 |
Why?
| | Catecholamines | 3 | 2005 | 98 | 0.560 |
Why?
| | Blood Proteins | 1 | 2020 | 252 | 0.560 |
Why?
| | Interleukin-6 | 5 | 2024 | 778 | 0.560 |
Why?
| | Housing, Animal | 2 | 2016 | 46 | 0.560 |
Why?
| | Behavior | 1 | 2018 | 90 | 0.560 |
Why?
| | Military Personnel | 3 | 2019 | 544 | 0.550 |
Why?
| | Physical Conditioning, Animal | 2 | 2019 | 257 | 0.550 |
Why?
| | Hypothermia | 1 | 2017 | 36 | 0.550 |
Why?
| | Signal Transduction | 5 | 2025 | 5079 | 0.550 |
Why?
| | Swimming | 3 | 2021 | 51 | 0.550 |
Why?
| | Gene Expression Regulation | 9 | 2018 | 2607 | 0.540 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2017 | 8 | 0.540 |
Why?
| | Proteomics | 2 | 2025 | 1111 | 0.540 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 860 | 0.530 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 195 | 0.530 |
Why?
| | Hypercapnia | 4 | 2012 | 53 | 0.530 |
Why?
| | Psychological Trauma | 1 | 2017 | 55 | 0.520 |
Why?
| | Prebiotics | 3 | 2024 | 27 | 0.520 |
Why?
| | Pets | 3 | 2025 | 26 | 0.520 |
Why?
| | Vaccination | 3 | 2020 | 1381 | 0.520 |
Why?
| | Circadian Rhythm | 4 | 2021 | 468 | 0.510 |
Why?
| | Parvalbumins | 2 | 2020 | 25 | 0.500 |
Why?
| | Lipid Metabolism | 1 | 2020 | 518 | 0.500 |
Why?
| | Immune System | 2 | 2014 | 177 | 0.500 |
Why?
| | Suicide, Attempted | 4 | 2025 | 378 | 0.490 |
Why?
| | Bacteria | 7 | 2025 | 858 | 0.480 |
Why?
| | Brain Concussion | 2 | 2020 | 574 | 0.470 |
Why?
| | Organic Anion Transporters, Sodium-Independent | 2 | 2019 | 4 | 0.460 |
Why?
| | Mice, Inbred C57BL | 13 | 2024 | 5757 | 0.460 |
Why?
| | Vasotocin | 4 | 2000 | 5 | 0.460 |
Why?
| | Gene Expression | 8 | 2020 | 1502 | 0.460 |
Why?
| | Social Determinants of Health | 1 | 2018 | 267 | 0.450 |
Why?
| | Post-Concussion Syndrome | 1 | 2017 | 175 | 0.430 |
Why?
| | Hormone Replacement Therapy | 1 | 2015 | 100 | 0.430 |
Why?
| | Immobility Response, Tonic | 1 | 2013 | 5 | 0.420 |
Why?
| | Conditioning, Classical | 5 | 2020 | 103 | 0.420 |
Why?
| | Cytokines | 7 | 2023 | 2085 | 0.420 |
Why?
| | Intestines | 2 | 2014 | 357 | 0.410 |
Why?
| | Pons | 2 | 2010 | 26 | 0.400 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2016 | 385 | 0.400 |
Why?
| | Mesencephalon | 2 | 2010 | 66 | 0.400 |
Why?
| | GABA Antagonists | 6 | 2013 | 35 | 0.390 |
Why?
| | Sex Characteristics | 2 | 2013 | 762 | 0.390 |
Why?
| | Life Style | 2 | 2014 | 490 | 0.390 |
Why?
| | Public Health | 2 | 2022 | 588 | 0.390 |
Why?
| | Adaptation, Psychological | 3 | 2014 | 655 | 0.390 |
Why?
| | Cold Temperature | 1 | 2013 | 179 | 0.380 |
Why?
| | Diet, High-Fat | 3 | 2024 | 247 | 0.380 |
Why?
| | Prosencephalon | 6 | 2018 | 48 | 0.370 |
Why?
| | Cushing Syndrome | 1 | 2011 | 10 | 0.370 |
Why?
| | Time Factors | 12 | 2015 | 6828 | 0.370 |
Why?
| | GABAergic Neurons | 1 | 2012 | 35 | 0.370 |
Why?
| | Immunoglobulin G | 5 | 2025 | 893 | 0.370 |
Why?
| | Female | 44 | 2025 | 73304 | 0.360 |
Why?
| | Brain Mapping | 5 | 2007 | 503 | 0.360 |
Why?
| | DNA, Bacterial | 3 | 2024 | 337 | 0.360 |
Why?
| | Kynurenine | 5 | 2018 | 114 | 0.360 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2017 | 198 | 0.360 |
Why?
| | Dose-Response Relationship, Drug | 12 | 2015 | 2057 | 0.350 |
Why?
| | Aging | 5 | 2024 | 1864 | 0.350 |
Why?
| | Rats, Long-Evans | 6 | 2021 | 125 | 0.350 |
Why?
| | Suicidal Ideation | 3 | 2025 | 529 | 0.350 |
Why?
| | Bronchi | 1 | 2012 | 260 | 0.340 |
Why?
| | Socioeconomic Factors | 2 | 2014 | 1289 | 0.340 |
Why?
| | Third Ventricle | 1 | 2010 | 17 | 0.330 |
Why?
| | Breast Neoplasms | 1 | 2022 | 2253 | 0.330 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 151 | 0.330 |
Why?
| | Light | 3 | 2008 | 381 | 0.330 |
Why?
| | Animals, Newborn | 5 | 2018 | 844 | 0.320 |
Why?
| | Suicide | 4 | 2020 | 656 | 0.320 |
Why?
| | Fenfluramine | 1 | 2009 | 14 | 0.310 |
Why?
| | Interneurons | 1 | 2010 | 122 | 0.310 |
Why?
| | Sequence Analysis, DNA | 2 | 2024 | 812 | 0.310 |
Why?
| | Cognition | 4 | 2022 | 1153 | 0.300 |
Why?
| | Amish | 2 | 2019 | 7 | 0.300 |
Why?
| | TRPV Cation Channels | 1 | 2008 | 40 | 0.300 |
Why?
| | Antibodies, Protozoan | 4 | 2025 | 36 | 0.290 |
Why?
| | Brain Chemistry | 4 | 2007 | 117 | 0.290 |
Why?
| | Medulla Oblongata | 4 | 2012 | 35 | 0.290 |
Why?
| | Sexual Behavior, Animal | 4 | 2006 | 57 | 0.290 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2018 | 597 | 0.280 |
Why?
| | RNA, Bacterial | 2 | 2020 | 190 | 0.280 |
Why?
| | Schizophrenia | 3 | 2016 | 439 | 0.280 |
Why?
| | Sleep Deprivation | 2 | 2020 | 174 | 0.280 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2008 | 137 | 0.270 |
Why?
| | Encephalitis | 2 | 2020 | 136 | 0.270 |
Why?
| | Pregnancy Trimester, First | 2 | 2025 | 140 | 0.270 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.270 |
Why?
| | Relaxin | 2 | 2018 | 20 | 0.270 |
Why?
| | Neuropeptides | 3 | 2018 | 73 | 0.270 |
Why?
| | Periaqueductal Gray | 3 | 2017 | 40 | 0.270 |
Why?
| | Allosteric Site | 1 | 2007 | 19 | 0.270 |
Why?
| | Age Factors | 7 | 2021 | 3295 | 0.260 |
Why?
| | Receptors, Interleukin-6 | 2 | 2024 | 43 | 0.260 |
Why?
| | Rats, Inbred F344 | 4 | 2019 | 265 | 0.260 |
Why?
| | Limbic System | 1 | 2007 | 47 | 0.260 |
Why?
| | Vaccines | 1 | 2012 | 406 | 0.260 |
Why?
| | Maze Learning | 6 | 2021 | 103 | 0.250 |
Why?
| | Restraint, Physical | 4 | 2015 | 72 | 0.250 |
Why?
| | Histamine | 2 | 2006 | 67 | 0.250 |
Why?
| | Up-Regulation | 4 | 2012 | 843 | 0.250 |
Why?
| | 5-Hydroxytryptophan | 5 | 2022 | 21 | 0.250 |
Why?
| | Indomethacin | 1 | 2006 | 81 | 0.250 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2006 | 79 | 0.250 |
Why?
| | Receptors, Serotonin, 5-HT3 | 1 | 2005 | 15 | 0.240 |
Why?
| | Biguanides | 1 | 2005 | 12 | 0.240 |
Why?
| | Adult | 24 | 2025 | 37929 | 0.240 |
Why?
| | Telemetry | 2 | 2017 | 40 | 0.240 |
Why?
| | In Situ Hybridization | 5 | 2012 | 316 | 0.240 |
Why?
| | Benzodiazepines | 1 | 2007 | 155 | 0.240 |
Why?
| | Prolactin | 2 | 2005 | 96 | 0.240 |
Why?
| | Hypothalamic Area, Lateral | 1 | 2005 | 2 | 0.240 |
Why?
| | Receptors, GABA-A | 1 | 2007 | 142 | 0.240 |
Why?
| | Environmental Microbiology | 2 | 2019 | 53 | 0.230 |
Why?
| | Microdialysis | 6 | 2025 | 52 | 0.230 |
Why?
| | Vimentin | 1 | 2005 | 52 | 0.230 |
Why?
| | Adrenal Medulla | 1 | 2004 | 9 | 0.220 |
Why?
| | Onchocerciasis | 2 | 2001 | 7 | 0.220 |
Why?
| | Antibodies, Bacterial | 1 | 2025 | 146 | 0.220 |
Why?
| | Healthy Aging | 1 | 2024 | 35 | 0.220 |
Why?
| | Life Change Events | 1 | 2005 | 151 | 0.220 |
Why?
| | Glucans | 1 | 2024 | 24 | 0.220 |
Why?
| | Criminology | 1 | 2024 | 2 | 0.220 |
Why?
| | Fibroblast Growth Factor 8 | 2 | 2014 | 27 | 0.220 |
Why?
| | Insect Vectors | 2 | 2001 | 39 | 0.220 |
Why?
| | Intra-Abdominal Fat | 1 | 2024 | 91 | 0.220 |
Why?
| | Adjuvants, Pharmaceutic | 1 | 2023 | 11 | 0.220 |
Why?
| | Oligosaccharides | 1 | 2024 | 60 | 0.210 |
Why?
| | Specimen Handling | 1 | 2025 | 183 | 0.210 |
Why?
| | Neuroimmunomodulation | 2 | 2019 | 65 | 0.210 |
Why?
| | Helicobacter Infections | 2 | 2021 | 32 | 0.210 |
Why?
| | Progesterone | 2 | 2025 | 254 | 0.210 |
Why?
| | Middle Aged | 16 | 2025 | 33479 | 0.210 |
Why?
| | Dopamine | 3 | 2018 | 303 | 0.210 |
Why?
| | Mice, Inbred Strains | 2 | 2023 | 409 | 0.210 |
Why?
| | Tuberculosis, Bovine | 1 | 2023 | 4 | 0.210 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 2018 | 32 | 0.210 |
Why?
| | Bile Acids and Salts | 2 | 2024 | 200 | 0.210 |
Why?
| | Cerebral Cortex | 1 | 2007 | 433 | 0.210 |
Why?
| | Diazepam | 1 | 2023 | 35 | 0.210 |
Why?
| | Estrogens | 2 | 2025 | 367 | 0.210 |
Why?
| | Macrophages | 2 | 2023 | 1547 | 0.200 |
Why?
| | Leptin | 1 | 2024 | 236 | 0.200 |
Why?
| | Administration, Oral | 1 | 2025 | 816 | 0.190 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 226 | 0.190 |
Why?
| | Receptors, Neuropeptide | 2 | 2012 | 12 | 0.190 |
Why?
| | Friends | 1 | 2023 | 52 | 0.190 |
Why?
| | Mucins | 1 | 2022 | 73 | 0.190 |
Why?
| | Random Allocation | 4 | 2009 | 353 | 0.190 |
Why?
| | Planets | 1 | 2021 | 1 | 0.190 |
Why?
| | Coinfection | 1 | 2023 | 137 | 0.190 |
Why?
| | Norepinephrine | 5 | 2005 | 204 | 0.190 |
Why?
| | Estradiol | 2 | 2025 | 521 | 0.190 |
Why?
| | Hydrazines | 3 | 2018 | 35 | 0.180 |
Why?
| | Serotonin Antagonists | 2 | 2015 | 32 | 0.180 |
Why?
| | Neopterin | 2 | 2022 | 12 | 0.180 |
Why?
| | Populus | 1 | 2021 | 12 | 0.180 |
Why?
| | Hygiene | 2 | 2014 | 30 | 0.180 |
Why?
| | Helicobacter pylori | 1 | 2021 | 42 | 0.180 |
Why?
| | Piperazines | 3 | 2010 | 350 | 0.180 |
Why?
| | Insect Bites and Stings | 1 | 2001 | 12 | 0.180 |
Why?
| | Adrenalectomy | 2 | 2015 | 68 | 0.170 |
Why?
| | Cholera Toxin | 3 | 2013 | 32 | 0.170 |
Why?
| | Brain Stem | 3 | 2006 | 94 | 0.170 |
Why?
| | Epinephrine | 2 | 2005 | 139 | 0.170 |
Why?
| | Frailty | 1 | 2024 | 170 | 0.170 |
Why?
| | Groundwater | 1 | 2021 | 40 | 0.170 |
Why?
| | Diptera | 1 | 2001 | 30 | 0.170 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2025 | 394 | 0.170 |
Why?
| | Escape Reaction | 2 | 2017 | 62 | 0.170 |
Why?
| | Temporomandibular Joint | 1 | 2020 | 8 | 0.170 |
Why?
| | Carrier Proteins | 1 | 2005 | 771 | 0.170 |
Why?
| | United States | 7 | 2025 | 14841 | 0.170 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1092 | 0.170 |
Why?
| | Multiple Trauma | 1 | 2021 | 100 | 0.170 |
Why?
| | Pregnancy Complications | 1 | 2025 | 527 | 0.160 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2012 | 220 | 0.160 |
Why?
| | Gain of Function Mutation | 1 | 2020 | 36 | 0.160 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 11 | 0.160 |
Why?
| | Mycobacterium tuberculosis | 1 | 2023 | 314 | 0.160 |
Why?
| | Neuropsychiatry | 1 | 2020 | 17 | 0.160 |
Why?
| | Urban Population | 2 | 2025 | 479 | 0.160 |
Why?
| | Shock | 1 | 2021 | 98 | 0.160 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 55 | 0.160 |
Why?
| | Adiposity | 1 | 2024 | 518 | 0.160 |
Why?
| | Autoradiography | 2 | 2009 | 78 | 0.160 |
Why?
| | Communicable Diseases | 1 | 2022 | 159 | 0.160 |
Why?
| | Periodontitis | 1 | 2020 | 53 | 0.160 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2019 | 3 | 0.160 |
Why?
| | Mice, 129 Strain | 1 | 2019 | 88 | 0.150 |
Why?
| | Psycholinguistics | 1 | 2019 | 20 | 0.150 |
Why?
| | Phobic Disorders | 1 | 2019 | 33 | 0.150 |
Why?
| | Individuality | 2 | 2019 | 156 | 0.150 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 50 | 0.150 |
Why?
| | United States Department of Veterans Affairs | 2 | 2024 | 678 | 0.150 |
Why?
| | Memory, Episodic | 1 | 2019 | 52 | 0.150 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 11 | 0.150 |
Why?
| | Health Promotion | 1 | 2024 | 741 | 0.150 |
Why?
| | Hypothalamus, Middle | 2 | 2010 | 2 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 363 | 0.150 |
Why?
| | Alarmins | 1 | 2018 | 26 | 0.140 |
Why?
| | Yohimbine | 2 | 2010 | 10 | 0.140 |
Why?
| | HMGB1 Protein | 1 | 2018 | 50 | 0.140 |
Why?
| | Biogenic Monoamines | 2 | 2009 | 16 | 0.140 |
Why?
| | Nervous System | 1 | 1998 | 67 | 0.140 |
Why?
| | Housing | 1 | 2019 | 146 | 0.140 |
Why?
| | Vasopressins | 1 | 1998 | 64 | 0.140 |
Why?
| | Nesting Behavior | 1 | 2018 | 16 | 0.140 |
Why?
| | Vertebrates | 1 | 1998 | 60 | 0.140 |
Why?
| | Phenylalanine | 1 | 2018 | 68 | 0.140 |
Why?
| | Injections, Intraventricular | 2 | 2009 | 55 | 0.140 |
Why?
| | Mice, Knockout | 4 | 2019 | 3015 | 0.140 |
Why?
| | Grooming | 2 | 2009 | 8 | 0.140 |
Why?
| | Adiponectin | 1 | 2020 | 244 | 0.140 |
Why?
| | Trauma and Stressor Related Disorders | 1 | 2017 | 2 | 0.140 |
Why?
| | MicroRNAs | 2 | 2014 | 692 | 0.140 |
Why?
| | Amphibians | 1 | 1998 | 57 | 0.140 |
Why?
| | Autism Spectrum Disorder | 2 | 2020 | 395 | 0.140 |
Why?
| | Desipramine | 2 | 2015 | 9 | 0.140 |
Why?
| | Genetic Fitness | 1 | 2018 | 59 | 0.140 |
Why?
| | Food Chain | 1 | 2017 | 41 | 0.140 |
Why?
| | Noise | 1 | 2018 | 65 | 0.130 |
Why?
| | Tyrosine | 1 | 2018 | 222 | 0.130 |
Why?
| | Helicobacter | 1 | 2016 | 4 | 0.130 |
Why?
| | Receptors, Glucocorticoid | 2 | 2017 | 155 | 0.130 |
Why?
| | Pilot Projects | 2 | 2024 | 1710 | 0.130 |
Why?
| | Songbirds | 1 | 2018 | 47 | 0.130 |
Why?
| | Biomarkers | 3 | 2024 | 4149 | 0.130 |
Why?
| | Gliadin | 1 | 2016 | 13 | 0.130 |
Why?
| | Tissue Distribution | 3 | 2006 | 332 | 0.130 |
Why?
| | Soil Microbiology | 1 | 2019 | 218 | 0.130 |
Why?
| | Impulsive Behavior | 1 | 2018 | 150 | 0.130 |
Why?
| | Video Recording | 2 | 2009 | 180 | 0.130 |
Why?
| | Altitude | 1 | 2021 | 488 | 0.130 |
Why?
| | Psychomotor Performance | 1 | 2019 | 309 | 0.130 |
Why?
| | Hydrocortisone | 2 | 2018 | 322 | 0.130 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 596 | 0.130 |
Why?
| | Global Health | 1 | 2019 | 386 | 0.130 |
Why?
| | Drug Administration Routes | 2 | 2007 | 38 | 0.130 |
Why?
| | Immunity, Cellular | 1 | 2018 | 268 | 0.130 |
Why?
| | Species Specificity | 3 | 2023 | 585 | 0.130 |
Why?
| | Obesity | 3 | 2024 | 2992 | 0.130 |
Why?
| | Down-Regulation | 1 | 2018 | 657 | 0.130 |
Why?
| | Biogenic Amines | 1 | 1996 | 4 | 0.120 |
Why?
| | Young Adult | 7 | 2025 | 13209 | 0.120 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.120 |
Why?
| | Epilepsy | 1 | 2020 | 333 | 0.120 |
Why?
| | Lipids | 1 | 2020 | 672 | 0.120 |
Why?
| | Affect | 1 | 2018 | 292 | 0.120 |
Why?
| | Adrenal Glands | 2 | 2016 | 78 | 0.120 |
Why?
| | Rectum | 1 | 2017 | 185 | 0.120 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1236 | 0.120 |
Why?
| | Staining and Labeling | 2 | 2006 | 150 | 0.120 |
Why?
| | Radioimmunoassay | 2 | 2009 | 173 | 0.120 |
Why?
| | Leukocytes, Mononuclear | 1 | 2018 | 558 | 0.120 |
Why?
| | Membrane Potentials | 1 | 1996 | 284 | 0.120 |
Why?
| | Cohort Studies | 3 | 2024 | 5742 | 0.120 |
Why?
| | Learning | 1 | 2019 | 409 | 0.110 |
Why?
| | Argonaute Proteins | 1 | 2014 | 27 | 0.110 |
Why?
| | Feedback, Physiological | 1 | 2015 | 77 | 0.110 |
Why?
| | Receptors, Steroid | 1 | 1995 | 50 | 0.110 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5472 | 0.110 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2014 | 46 | 0.110 |
Why?
| | Extracellular Space | 2 | 2019 | 119 | 0.110 |
Why?
| | Metabolic Networks and Pathways | 1 | 2015 | 180 | 0.110 |
Why?
| | Urbanization | 1 | 2014 | 29 | 0.110 |
Why?
| | Quality of Life | 2 | 2024 | 2892 | 0.110 |
Why?
| | Diet | 4 | 2024 | 1278 | 0.110 |
Why?
| | Chronic Disease | 2 | 2019 | 1793 | 0.110 |
Why?
| | White Matter | 1 | 2016 | 145 | 0.110 |
Why?
| | Sleep | 4 | 2021 | 755 | 0.110 |
Why?
| | Rural Population | 1 | 2018 | 563 | 0.110 |
Why?
| | Oncogene Proteins v-fos | 1 | 2013 | 11 | 0.110 |
Why?
| | Hypoxia | 1 | 2021 | 1112 | 0.110 |
Why?
| | Alzheimer Disease | 1 | 2020 | 560 | 0.110 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 53 | 0.110 |
Why?
| | Bradycardia | 2 | 2012 | 55 | 0.100 |
Why?
| | Proteins | 1 | 2020 | 1009 | 0.100 |
Why?
| | Emigration and Immigration | 1 | 2014 | 46 | 0.100 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 2013 | 30 | 0.100 |
Why?
| | Respiration Disorders | 1 | 2014 | 77 | 0.100 |
Why?
| | Receptors, Angiotensin | 1 | 2013 | 12 | 0.100 |
Why?
| | Biological Evolution | 2 | 2014 | 474 | 0.100 |
Why?
| | Receptors, Opioid | 2 | 1990 | 25 | 0.100 |
Why?
| | Seasons | 3 | 2020 | 547 | 0.100 |
Why?
| | Comorbidity | 2 | 2017 | 1622 | 0.100 |
Why?
| | Deoxyadenine Nucleotides | 1 | 2013 | 14 | 0.100 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 383 | 0.100 |
Why?
| | Skin | 3 | 2023 | 752 | 0.100 |
Why?
| | Rodentia | 1 | 2013 | 57 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 852 | 0.100 |
Why?
| | Follow-Up Studies | 3 | 2018 | 5131 | 0.100 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2011 | 143 | 0.100 |
Why?
| | Amphetamine | 1 | 2012 | 35 | 0.100 |
Why?
| | Body Weight | 1 | 2017 | 985 | 0.100 |
Why?
| | Avoidance Learning | 1 | 2013 | 76 | 0.100 |
Why?
| | Angiotensin II | 1 | 2013 | 99 | 0.100 |
Why?
| | Serotonin 5-HT1 Receptor Agonists | 1 | 2012 | 4 | 0.100 |
Why?
| | Sodium Lactate | 2 | 2013 | 5 | 0.100 |
Why?
| | Weaning | 1 | 2012 | 47 | 0.100 |
Why?
| | Resilience, Psychological | 1 | 2014 | 128 | 0.100 |
Why?
| | Brain Injuries | 1 | 2017 | 494 | 0.090 |
Why?
| | Memory | 3 | 2018 | 248 | 0.090 |
Why?
| | Phenotype | 3 | 2021 | 3196 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 621 | 0.090 |
Why?
| | Metagenomics | 2 | 2024 | 169 | 0.090 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2002 | 137 | 0.090 |
Why?
| | Aged | 5 | 2024 | 23961 | 0.090 |
Why?
| | Electroshock | 3 | 2017 | 142 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 145 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2025 | 2189 | 0.080 |
Why?
| | Hypertension | 2 | 2012 | 1295 | 0.080 |
Why?
| | Neuronal Tract-Tracers | 1 | 2010 | 2 | 0.080 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2012 | 179 | 0.080 |
Why?
| | Radiography | 1 | 2013 | 822 | 0.080 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2010 | 20 | 0.080 |
Why?
| | Sanitation | 1 | 2010 | 55 | 0.080 |
Why?
| | Receptors, Adrenergic | 2 | 2006 | 33 | 0.080 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 192 | 0.080 |
Why?
| | Cell Lineage | 1 | 2012 | 350 | 0.080 |
Why?
| | Injections, Intraperitoneal | 2 | 2009 | 114 | 0.080 |
Why?
| | HIV Infections | 1 | 2024 | 2836 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2010 | 91 | 0.080 |
Why?
| | Feeding Behavior | 2 | 2006 | 654 | 0.080 |
Why?
| | Environmental Exposure | 1 | 2014 | 579 | 0.080 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 390 | 0.080 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2007 | 72 | 0.080 |
Why?
| | Social Dominance | 1 | 2009 | 21 | 0.080 |
Why?
| | Aromatic Amino Acid Decarboxylase Inhibitors | 1 | 2009 | 1 | 0.080 |
Why?
| | Thermosensing | 1 | 2008 | 12 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 455 | 0.080 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1023 | 0.080 |
Why?
| | Pregnancy | 5 | 2025 | 6763 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2011 | 2139 | 0.070 |
Why?
| | Pyridines | 2 | 2013 | 506 | 0.070 |
Why?
| | Transfection | 1 | 2011 | 945 | 0.070 |
Why?
| | Pargyline | 1 | 2008 | 2 | 0.070 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2008 | 12 | 0.070 |
Why?
| | Biological Transport | 2 | 2006 | 418 | 0.070 |
Why?
| | Seroepidemiologic Studies | 2 | 2019 | 165 | 0.070 |
Why?
| | Immune Tolerance | 1 | 2010 | 363 | 0.070 |
Why?
| | Temperature | 1 | 2011 | 679 | 0.070 |
Why?
| | Mice, Transgenic | 4 | 2014 | 2167 | 0.070 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 417 | 0.070 |
Why?
| | Central Nervous System Stimulants | 2 | 2012 | 161 | 0.070 |
Why?
| | Somatoform Disorders | 1 | 2007 | 38 | 0.070 |
Why?
| | Acoustic Stimulation | 1 | 2009 | 312 | 0.070 |
Why?
| | Self Report | 2 | 2024 | 827 | 0.070 |
Why?
| | Exercise | 2 | 2024 | 2057 | 0.070 |
Why?
| | Bronchopulmonary Sequestration | 1 | 2007 | 8 | 0.070 |
Why?
| | Statistics as Topic | 1 | 2008 | 307 | 0.070 |
Why?
| | Tryptamines | 1 | 2006 | 5 | 0.070 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2007 | 141 | 0.070 |
Why?
| | Synapses | 1 | 2010 | 427 | 0.060 |
Why?
| | Darkness | 1 | 2006 | 28 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 740 | 0.060 |
Why?
| | Tegmentum Mesencephali | 1 | 2006 | 5 | 0.060 |
Why?
| | Heart Rate | 2 | 2025 | 822 | 0.060 |
Why?
| | Genotype | 3 | 2020 | 1916 | 0.060 |
Why?
| | Tissue Fixation | 1 | 2005 | 36 | 0.060 |
Why?
| | Genome-Wide Association Study | 2 | 2025 | 1431 | 0.060 |
Why?
| | Cell Membrane | 2 | 2022 | 738 | 0.060 |
Why?
| | Peptide Fragments | 2 | 2008 | 706 | 0.060 |
Why?
| | Chromatography, Liquid | 2 | 2021 | 433 | 0.060 |
Why?
| | Drug Interactions | 1 | 2007 | 410 | 0.060 |
Why?
| | Median Eminence | 1 | 2005 | 5 | 0.060 |
Why?
| | Serogroup | 1 | 2025 | 44 | 0.060 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2005 | 16 | 0.060 |
Why?
| | Blood-Brain Barrier | 1 | 2006 | 138 | 0.060 |
Why?
| | Stilbamidines | 1 | 2005 | 10 | 0.060 |
Why?
| | Injections | 1 | 2005 | 183 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 752 | 0.060 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2005 | 36 | 0.060 |
Why?
| | Heart Atria | 1 | 2005 | 137 | 0.060 |
Why?
| | Autoimmunity | 1 | 2010 | 908 | 0.060 |
Why?
| | Blood Pressure | 2 | 2013 | 1786 | 0.060 |
Why?
| | Microinjections | 2 | 2015 | 86 | 0.060 |
Why?
| | Neurons, Efferent | 1 | 2004 | 8 | 0.060 |
Why?
| | Nerve Fibers | 1 | 2005 | 96 | 0.060 |
Why?
| | Genes, Immediate-Early | 1 | 2004 | 21 | 0.060 |
Why?
| | Mind-Body Therapies | 1 | 2024 | 7 | 0.060 |
Why?
| | Lomustine | 1 | 2024 | 14 | 0.050 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 182 | 0.050 |
Why?
| | Perfusion | 1 | 2005 | 213 | 0.050 |
Why?
| | Ovariectomy | 1 | 2025 | 152 | 0.050 |
Why?
| | Colorado | 2 | 2024 | 4565 | 0.050 |
Why?
| | Brazil | 2 | 2001 | 167 | 0.050 |
Why?
| | Mouth | 1 | 2024 | 87 | 0.050 |
Why?
| | Risk Factors | 3 | 2025 | 10388 | 0.050 |
Why?
| | Crime | 1 | 2024 | 60 | 0.050 |
Why?
| | Metagenome | 1 | 2024 | 147 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3284 | 0.050 |
Why?
| | Criminal Law | 1 | 2024 | 31 | 0.050 |
Why?
| | Action Potentials | 2 | 2011 | 493 | 0.050 |
Why?
| | Saliva | 1 | 2025 | 242 | 0.050 |
Why?
| | Drosophila Proteins | 2 | 2002 | 204 | 0.050 |
Why?
| | Prednisone | 1 | 2024 | 240 | 0.050 |
Why?
| | Rats, Inbred Lew | 1 | 2003 | 114 | 0.050 |
Why?
| | Carbidopa | 1 | 2022 | 4 | 0.050 |
Why?
| | Neurodegenerative Diseases | 1 | 2024 | 135 | 0.050 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2016 | 547 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 289 | 0.050 |
Why?
| | Orexin Receptors | 2 | 2012 | 5 | 0.050 |
Why?
| | Psychoneuroimmunology | 1 | 2022 | 10 | 0.050 |
Why?
| | Fever | 1 | 2024 | 306 | 0.050 |
Why?
| | Blotting, Western | 1 | 2005 | 1226 | 0.050 |
Why?
| | Fathers | 1 | 2022 | 50 | 0.050 |
Why?
| | Blood Glucose | 2 | 2011 | 2186 | 0.050 |
Why?
| | Models, Biological | 2 | 2007 | 1783 | 0.050 |
Why?
| | Polysomnography | 2 | 2019 | 185 | 0.050 |
Why?
| | Bacteroidetes | 1 | 2021 | 24 | 0.050 |
Why?
| | Eye | 1 | 2002 | 108 | 0.050 |
Why?
| | Simuliidae | 1 | 2001 | 1 | 0.050 |
Why?
| | Social Justice | 1 | 2022 | 73 | 0.040 |
Why?
| | Counseling | 1 | 2024 | 391 | 0.040 |
Why?
| | Endophenotypes | 1 | 2021 | 21 | 0.040 |
Why?
| | Anhedonia | 1 | 2021 | 13 | 0.040 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2023 | 205 | 0.040 |
Why?
| | Supervised Machine Learning | 1 | 2021 | 17 | 0.040 |
Why?
| | Granulocytes | 1 | 2021 | 80 | 0.040 |
Why?
| | Biodegradation, Environmental | 1 | 2021 | 84 | 0.040 |
Why?
| | Microfilament Proteins | 1 | 2022 | 133 | 0.040 |
Why?
| | Dietary Sucrose | 1 | 2021 | 49 | 0.040 |
Why?
| | Linkage Disequilibrium | 1 | 2001 | 268 | 0.040 |
Why?
| | Rivers | 1 | 2021 | 64 | 0.040 |
Why?
| | Trees | 1 | 2021 | 71 | 0.040 |
Why?
| | Dreams | 1 | 2000 | 11 | 0.040 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 243 | 0.040 |
Why?
| | Cations | 1 | 2021 | 84 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 984 | 0.040 |
Why?
| | Microelectrodes | 1 | 2000 | 45 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2023 | 273 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 218 | 0.040 |
Why?
| | Choice Behavior | 1 | 2022 | 170 | 0.040 |
Why?
| | Policy | 1 | 2022 | 150 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2024 | 539 | 0.040 |
Why?
| | Social Support | 1 | 2024 | 618 | 0.040 |
Why?
| | Benzomorphans | 2 | 1990 | 2 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2000 | 80 | 0.040 |
Why?
| | Program Evaluation | 1 | 2024 | 898 | 0.040 |
Why?
| | Cathelicidins | 1 | 2020 | 41 | 0.040 |
Why?
| | Population Dynamics | 1 | 2001 | 151 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 956 | 0.040 |
Why?
| | DNA, Ribosomal | 1 | 2020 | 88 | 0.040 |
Why?
| | Sleep Apnea Syndromes | 1 | 2000 | 88 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 81 | 0.040 |
Why?
| | Normetanephrine | 1 | 2019 | 2 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2020 | 523 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 554 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1993 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2019 | 90 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2019 | 83 | 0.040 |
Why?
| | Social Environment | 2 | 2010 | 296 | 0.040 |
Why?
| | Photic Stimulation | 1 | 2020 | 241 | 0.040 |
Why?
| | Reaction Time | 1 | 2000 | 412 | 0.040 |
Why?
| | Lymphocytes | 1 | 2021 | 397 | 0.040 |
Why?
| | Axons | 1 | 2000 | 198 | 0.040 |
Why?
| | Interpersonal Relations | 2 | 2015 | 397 | 0.040 |
Why?
| | Asthma | 1 | 2012 | 2295 | 0.040 |
Why?
| | Bipolar Disorder | 1 | 2001 | 263 | 0.040 |
Why?
| | Patient Care Team | 1 | 2024 | 631 | 0.040 |
Why?
| | Optogenetics | 1 | 2020 | 108 | 0.040 |
Why?
| | Patient-Centered Care | 1 | 2024 | 530 | 0.040 |
Why?
| | Electroencephalography | 1 | 2021 | 423 | 0.040 |
Why?
| | Genetic Testing | 1 | 2001 | 460 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 125 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 532 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 183 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 380 | 0.040 |
Why?
| | Serologic Tests | 1 | 2018 | 54 | 0.040 |
Why?
| | Metabolome | 1 | 2021 | 350 | 0.040 |
Why?
| | Extracellular Fluid | 2 | 2010 | 31 | 0.040 |
Why?
| | Agoraphobia | 1 | 2017 | 8 | 0.040 |
Why?
| | Germany | 1 | 2018 | 121 | 0.040 |
Why?
| | Feathers | 1 | 2018 | 37 | 0.040 |
Why?
| | Nucleic Acid Probes | 1 | 1997 | 2 | 0.030 |
Why?
| | Ethylmaleimide | 1 | 1997 | 18 | 0.030 |
Why?
| | Thionucleotides | 1 | 1997 | 35 | 0.030 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2017 | 45 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2018 | 199 | 0.030 |
Why?
| | Biodiversity | 1 | 2021 | 409 | 0.030 |
Why?
| | Dogs | 1 | 2018 | 413 | 0.030 |
Why?
| | Picrotoxin | 1 | 2017 | 12 | 0.030 |
Why?
| | Body Size | 1 | 2018 | 108 | 0.030 |
Why?
| | Nerve Net | 1 | 2020 | 256 | 0.030 |
Why?
| | Oxytocin | 1 | 1997 | 51 | 0.030 |
Why?
| | Quinolines | 2 | 2010 | 178 | 0.030 |
Why?
| | Arizona | 1 | 2016 | 81 | 0.030 |
Why?
| | Anisotropy | 1 | 2016 | 79 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 402 | 0.030 |
Why?
| | 5,7-Dihydroxytryptamine | 1 | 2015 | 3 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2024 | 10811 | 0.030 |
Why?
| | Attention | 1 | 2019 | 427 | 0.030 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2015 | 17 | 0.030 |
Why?
| | Organ Size | 1 | 2016 | 477 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 644 | 0.030 |
Why?
| | Diffusion Tensor Imaging | 1 | 2016 | 79 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 312 | 0.030 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 9 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 795 | 0.030 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2014 | 22 | 0.030 |
Why?
| | Rabbits | 1 | 2016 | 794 | 0.030 |
Why?
| | Mifepristone | 1 | 2014 | 64 | 0.030 |
Why?
| | Environment | 1 | 2017 | 358 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 840 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 119 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1199 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 451 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2016 | 246 | 0.030 |
Why?
| | Electrochemical Techniques | 1 | 2014 | 54 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 351 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2015 | 130 | 0.030 |
Why?
| | Immune System Diseases | 1 | 2014 | 39 | 0.030 |
Why?
| | Catalysis | 1 | 2014 | 307 | 0.030 |
Why?
| | Memory Disorders | 1 | 2014 | 164 | 0.030 |
Why?
| | Receptors, Opioid, kappa | 2 | 1990 | 10 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2016 | 611 | 0.030 |
Why?
| | Heterozygote | 1 | 2014 | 293 | 0.030 |
Why?
| | Mothers | 1 | 1999 | 754 | 0.030 |
Why?
| | Angiotensin II Type 2 Receptor Blockers | 1 | 2013 | 7 | 0.030 |
Why?
| | Cues | 1 | 2015 | 314 | 0.030 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 38 | 0.030 |
Why?
| | Adaptation, Physiological | 2 | 2009 | 553 | 0.020 |
Why?
| | Prospective Studies | 1 | 2025 | 7604 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1639 | 0.020 |
Why?
| | Odds Ratio | 1 | 2015 | 1070 | 0.020 |
Why?
| | Orexins | 1 | 2012 | 6 | 0.020 |
Why?
| | Naphthyridines | 1 | 2012 | 19 | 0.020 |
Why?
| | Benzoxazoles | 1 | 2012 | 19 | 0.020 |
Why?
| | Androgens | 1 | 1994 | 187 | 0.020 |
Why?
| | Naloxone | 2 | 1990 | 122 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2071 | 0.020 |
Why?
| | Urea | 1 | 2012 | 81 | 0.020 |
Why?
| | Imidazoles | 1 | 2013 | 238 | 0.020 |
Why?
| | Eye Proteins | 2 | 2002 | 92 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2844 | 0.020 |
Why?
| | Respiration | 1 | 2012 | 199 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 346 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2010 | 60 | 0.020 |
Why?
| | Muscle Strength | 1 | 2014 | 317 | 0.020 |
Why?
| | Fetal Development | 1 | 2014 | 296 | 0.020 |
Why?
| | Morphinans | 1 | 1989 | 8 | 0.020 |
Why?
| | Receptors, Opioid, mu | 1 | 1990 | 74 | 0.020 |
Why?
| | Organic Chemicals | 1 | 2010 | 124 | 0.020 |
Why?
| | Morphine | 1 | 1990 | 158 | 0.020 |
Why?
| | Allylglycine | 1 | 2007 | 2 | 0.020 |
Why?
| | Choline O-Acetyltransferase | 1 | 2007 | 24 | 0.020 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2007 | 26 | 0.020 |
Why?
| | Mass Screening | 1 | 2016 | 1287 | 0.020 |
Why?
| | Pain | 1 | 2013 | 756 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2008 | 264 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2007 | 170 | 0.020 |
Why?
| | Pyrroles | 1 | 2008 | 213 | 0.020 |
Why?
| | Autonomic Nervous System | 1 | 2007 | 75 | 0.020 |
Why?
| | Child | 2 | 2019 | 21935 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4193 | 0.020 |
Why?
| | 1-Methyl-4-phenylpyridinium | 1 | 2006 | 5 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2007 | 169 | 0.020 |
Why?
| | Cimetidine | 1 | 1986 | 13 | 0.020 |
Why?
| | Ranitidine | 1 | 1986 | 14 | 0.020 |
Why?
| | Growth Hormone | 1 | 1986 | 101 | 0.010 |
Why?
| | Testis | 1 | 1986 | 151 | 0.010 |
Why?
| | Pyrimidines | 1 | 2008 | 470 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 431 | 0.010 |
Why?
| | Adolescent | 1 | 2024 | 21513 | 0.010 |
Why?
| | Inspiratory Capacity | 1 | 2004 | 3 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2004 | 282 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2426 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 3958 | 0.010 |
Why?
| | Reference Values | 1 | 2004 | 816 | 0.010 |
Why?
| | 5' Flanking Region | 1 | 2001 | 9 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 385 | 0.010 |
Why?
| | Insect Proteins | 1 | 2001 | 39 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2001 | 272 | 0.010 |
Why?
| | 3' Untranslated Regions | 1 | 2001 | 145 | 0.010 |
Why?
| | Microsatellite Repeats | 1 | 2001 | 168 | 0.010 |
Why?
| | Periodicity | 1 | 2000 | 58 | 0.010 |
Why?
| | DNA Primers | 1 | 2001 | 515 | 0.010 |
Why?
| | Introns | 1 | 2001 | 258 | 0.010 |
Why?
| | Exons | 1 | 2001 | 355 | 0.010 |
Why?
| | Drosophila | 1 | 2001 | 154 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 15657 | 0.010 |
Why?
| | Pyramidal Cells | 1 | 1999 | 74 | 0.010 |
Why?
| | Atrophy | 1 | 1999 | 184 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2002 | 2900 | 0.010 |
Why?
| | RNA, Complementary | 1 | 1997 | 3 | 0.010 |
Why?
| | Sulfur Radioisotopes | 1 | 1997 | 15 | 0.010 |
Why?
| | Thyrotropin-Releasing Hormone | 1 | 1997 | 10 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1997 | 51 | 0.010 |
Why?
| | Neuronal Plasticity | 1 | 1999 | 290 | 0.010 |
Why?
| | Body Mass Index | 1 | 2000 | 2389 | 0.010 |
Why?
| | Testosterone | 1 | 1994 | 409 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 5778 | 0.000 |
Why?
| | Dyspepsia | 1 | 1986 | 10 | 0.000 |
Why?
| | Gonadal Steroid Hormones | 1 | 1986 | 140 | 0.000 |
Why?
| | Glucose Tolerance Test | 1 | 1986 | 366 | 0.000 |
Why?
| | Insulin | 1 | 1986 | 2409 | 0.000 |
Why?
|
|
Lowry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|